Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

[1]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[2]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[3]  M. Stampfer,et al.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.

[4]  Eden R Martin,et al.  A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms , 2008, Genetic epidemiology.

[5]  E. Riboli,et al.  Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. , 2008, The American journal of clinical nutrition.

[6]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[7]  E. Riboli,et al.  Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.

[8]  F. Berrino,et al.  Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. , 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  S. Clarke,et al.  Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c. , 2007, The Biochemical journal.

[10]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  M. Loda,et al.  Gastrointestinal stromal tumours overexpress fatty acid synthase , 2006, The Journal of pathology.

[12]  E. Giovannucci,et al.  Role of diet in prostate cancer development and progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[14]  F. Berrino,et al.  Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC) , 2005, British Journal of Cancer.

[15]  J. Swinnen,et al.  RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells , 2005 .

[16]  A. Noël,et al.  Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. , 2005, Cancer research.

[17]  Matthias Egger,et al.  Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.

[18]  A. Stahl.  A current review of fatty acid transport proteins (SLC27) , 2004, Pflügers Archiv.

[19]  J. Swinnen,et al.  Epigallocatechin‐3‐gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells , 2003, International journal of cancer.

[20]  F. Field,et al.  Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression Published, JLR Papers in Press, March 16, 2003. DOI 10.1194/jlr.M300013-JLR200 , 2003, Journal of Lipid Research.

[21]  Suzuki Toshimitsu,et al.  Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[23]  F. Berrino,et al.  Fasting glucose is a risk factor for breast cancer: a prospective study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  Harri Vainio,et al.  Overweight, obesity, and cancer risk. , 2002, The Lancet. Oncology.

[25]  R. Kaaks,et al.  Effects of Weight Control and Physical Activity in Cancer Prevention , 2002, Annals of the New York Academy of Sciences.

[26]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[27]  T. Roskams,et al.  Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer , 2002, International journal of cancer.

[28]  E. Riboli,et al.  Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in Northern and Southern Sweden , 2002, Cancer Causes & Control.

[29]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[30]  M Parpinel,et al.  Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[32]  J. Sebolt-Leopold.  Development of anticancer drugs targeting the MAP kinase pathway , 2000, Oncogene.

[33]  R. Curi,et al.  Effect of fatty acids on leukocyte function. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[34]  F. Kuhajda.  Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. , 2000, Nutrition.

[35]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[36]  T. Gansler,et al.  Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. , 1997, Human pathology.

[37]  H. Adami,et al.  Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. , 1997, Journal of the National Cancer Institute.

[38]  R. Kaaks.  Nutrition, hormones, and breast cancer: Is insulin the missing link? , 1996, Cancer Causes & Control.

[39]  P. Edwards,et al.  Synergistic Binding of Sterol Regulatory Element-binding Protein and NF-Y to the Farnesyl Diphosphate Synthase Promoter Is Critical for Sterol-regulated Expression of the Gene* , 1996, The Journal of Biological Chemistry.

[40]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[41]  C. Pond,et al.  Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. , 1990, International journal of obesity.

[42]  L. Bernstein,et al.  CHAPTER 9 – Obesity and Cancer Risk , 2006 .

[43]  D. Clemmons,et al.  Nutritional regulation of IGF-I and IGF binding proteins. , 1991, Annual review of nutrition.

[44]  S. Weinhouse,et al.  Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. , 1953, Cancer research.